Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Wolfgang Rafflenbeul"'
Autor:
Dirk Hausmann, Hans-Georg Wolpers, Andreas Mügge, Matthias Sturm, Erwin Blessing, Ivo Amende, Wolfgang Rafflenbeul
Publikováno v:
The International Journal of Cardiac Imaging. 13:293-299
The absence of angiographic findings despite significant coronary artery disease has been previously described. Possible explanations for the limitation of plaque detection by angiography include compensatory vessel enlargement in face of intracorona
Autor:
Birgitt Wiese, Stefan Jost, Jaap W. Deckers, Wolfgang Rafflenbeul, Johan H. C. Reiber, Paul R. Lichtlen, Peter Nikutta, Hartmut Hecker
Publikováno v:
American Heart Journal. 130:433-439
In recent years follow-up trials on coronary artery disease with angiographic end points analyzed quantitatively have gained increasing relevance and popularity. There is no consensus, however, on the method of calculation of progression or regressio
Autor:
Rainer Uebis, Guy R. Heyndrickx, Patrick W. Serruys, Wolfgang Rutsch, Benno J. Rensing, Claude Hanet, Raphael Balcon, Wolfgang Rafflenbeul, Jean-Marc Lablanche, Nicolas Danchin, David P. Foley, Walter R.M. Hermans, Pim J. de Feyter, Gijs Mast
Publikováno v:
The American Journal of Cardiology. 72:14-20
Major, adverse cardiac events (death, myocardial infarction, bypass surgery and reintervention) occur in 4 to 7% of all patients undergoing coronary balloon angioplasty. Prospectively collected clinical data, and angiographic quantitative and qualita
Autor:
Wolfgang Rafflenbeul, Peter Nikutta, Jaap W. Deckers, Birgitt Wiese, Peter Lippolt, Paul R. Lichtlen, Hartmut Hecker, Stefan Jost
Publikováno v:
Journal of the American College of Cardiology. 21:1339-1346
Objectives. This study represents the first prospective, quantitative analysis of the association of progression of coronary atherosclerosis with anatomic site and diameter.Background. The progressive course of coronary artery disease has been docume
Publikováno v:
Circulation. 86:828-838
BACKGROUND At present, there is extensive knowledge on the clinical course of coronary artery disease (CAD), whereas data on the underlying anatomical changes and their relation to clinical events are still limited. METHODS AND RESULTS We investigate
Autor:
Jaap W. Deckers, Peter Lippolt, Birgitt Wiese, Wolfgang Rafflenbeul, Stefan Jost, Hartmut Hecker, Peter Nikutta, P. R. Lichtlen
Publikováno v:
European Journal of Epidemiology. 8:107-119
Animal experiments suggest an inhibitory effect of calcium entry blockers on arterial calcinosis and the formation of atherosclerotic plaques. Experiments with isolated tissues suggest various mechanisms for an antiatherosclerotic effect of calcium e
Autor:
Wolfgang Rafflenbeul, Hartmut Hecker, Jaap W. Deckers, Stefan Jost, Paul G. Hugenholtz, P. R. Lichtlen
Publikováno v:
The Lancet. 335:1109-1113
425 patients showing mild coronary artery disease (CAD) on arteriography were enrolled in a multicentre trial and randomised to treatment with nifedipine (80 mg/day) or placebo. The two groups were well matched for age, sex, and risk factors. 348 pat
Autor:
Paul R. Lichtlen, Jaap W. Deckers, Wolfgang Rafflenbeul, Peter Nikutta, Stefan Jost, Birgitt Wiese, Paul G. Hugenholtz
Publikováno v:
Developments in Cardiovascular Medicine ISBN: 9789401048194
INTACT is a study on the progression of coronary artery disease based on quantitated coronary angiography, applying the CAAS-system to assess the diameters of segments and stenoses and their changes over time. 348 of 425 patients (82%) underwent 2 an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a91ca0c6b4049d92f7bb02e0a03e4d25
https://doi.org/10.1007/978-94-011-1854-5_15
https://doi.org/10.1007/978-94-011-1854-5_15
Autor:
Stefan Jost, D. C. Gulba, Werner G. Daniel, Mechthild Westhoff-Bleck, Monika Barthels, Hartmut Hecker, Wolfgang Rafflenbeul, P. R. Lichtlen
Publikováno v:
Circulation. 83(3)
BACKGROUND It has been suggested that thrombolysis in a feedback reaction may generate pro-coagulant activities. METHODS AND RESULTS Fifty-five patients were treated with urokinase-preactivated prourokinase (n = 35) or tissue-type plasminogen activat
Autor:
Paul R. Lichtlen, Hartmut Hecker, Peter Nikutta, Wolfgang Rafflenbeul, Paul G. Hugenholtz, Birgitt Wiese, Jaap W. Deckers, Stefan Jost
Publikováno v:
Journal of the American College of Cardiology. 17(2)